Literature DB >> 2307727

Somatomedin-C, physical fitness, and bone density.

P J Kelly1, J A Eisman, M C Stuart, N A Pocock, P N Sambrook, T H Gwinn.   

Abstract

Somatomedin-C (Sm-C) or insulin-like growth factor-I, GH and physical fitness decline with age. Physical fitness and muscle strength are important determinants of bone density, and the age-related decline in bone density may be related in part to a decline in fitness and muscle strength. Also, Sm-C has been shown to stimulate osteoblasts in vitro and may effect skeletal muscle mass. We postulated that the age-related decline in GH and Sm-C levels may be related to an age-related decline in physical fitness and/or muscle strength, and the effect of physical fitness and muscle strength on bone may be mediated by Sm-C. We, therefore, examined the relationship between circulating GH and Sm-C levels and physical fitness, as determined by predicted maximal oxygen uptake (VO2max) in 134 normal women, 34 of whom were postmenopausal. In a subgroup of 62 women overall muscle strength was estimated as the sum of the Z-sores for biceps, quadriceps, and grip strength. Overall muscle strength correlated with GH levels (r = 0.28; P less than 0.02), but not with Sm-C levels. There was a significant positive relationship between plasma Sm-C levels and VO2max in all women (r = 0.47; P less than 0.001) and in the postmenopausal group alone (r = 0.05; P less than 0.01). Although there was a significant negative relationship between Sm-C and age (r = -0.36; P = 0.001), VO2max was a better independent predictor than age (r = 0.47; P = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307727     DOI: 10.1210/jcem-70-3-718

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  A personal history of veterinary public health.

Authors:  J H Steele
Journal:  Vet Herit       Date:  1996-12

2.  IGFBP-3, a sensitive marker of physical training and overtraining.

Authors:  M Elloumi; N El Elj; M Zaouali; F Maso; E Filaire; Z Tabka; G Lac
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

3.  Epidemiologic survey: reference ranges of serum insulin-like growth factor 1 levels in Caucasian adult population with immunoradiometric assay.

Authors:  Fahri Bayram; Vedia Tonyukuk Gedik; Özgür Demir; Ahmet Kaya; Kürşat Gündoğan; Rıfat Emral; Ahmet Öztürk; Ali Rıza Uysal; Demet Çorapçıoğlu
Journal:  Endocrine       Date:  2011-05-03       Impact factor: 3.633

Review 4.  IGFBP-3. Functional and structural implications in aging and wasting syndromes.

Authors:  M C Gelato; R A Frost
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 5.  Endogenous anabolic hormone responses to endurance versus resistance exercise and training in women.

Authors:  Leslie A Consitt; Jennifer L Copeland; Mark S Tremblay
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

6.  Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis.

Authors:  W Schmidt; S Doré; A Hilgendorf; S Strauch; R Gareau; G R Brisson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

Review 7.  Can vigorous exercise play a role in osteoporosis prevention? A review.

Authors:  B Gutin; M J Kasper
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

Review 8.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

9.  Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women.

Authors:  E Romagnoli; S Minisola; V Carnevale; A Scarda; R Rosso; L Scarnecchia; M T Pacitti; G Mazzuoli
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

10.  Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.

Authors:  M E Lloyd; D J Hart; D Nandra; T E McAlindon; M Wheeler; D V Doyle; T D Spector
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.